These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24499866)

  • 1. PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB.
    Faria Dde P; Copray S; Sijbesma JW; Willemsen AT; Buchpiguel CA; Dierckx RA; de Vries EF
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):995-1003. PubMed ID: 24499866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
    de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
    Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
    Auvity S; Tonietto M; Caillé F; Bodini B; Bottlaender M; Tournier N; Kuhnast B; Stankoff B
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):490-501. PubMed ID: 31686177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Carvalho RHF; Real CC; Cinini S; Garcez AT; Duran FLS; Marques FLN; Mello LE; Busatto Filho G; de Vries EFJ; de Britto LRG; Buchpiguel CA; de Paula Faria D
    Mult Scler Relat Disord; 2019 Oct; 35():108-115. PubMed ID: 31362166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord.
    Wu C; Zhu J; Baeslack J; Zaremba A; Hecker J; Kraso J; Matthews PM; Miller RH; Wang Y
    Ann Neurol; 2013 Nov; 74(5):688-98. PubMed ID: 23818306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!
    Zhang M; Hugon G; Bouillot C; Bolbos R; Langlois JB; Billard T; Bonnefoi F; Li B; Zimmer L; Chauveau F
    Contrast Media Mol Imaging; 2019; 2019():9294586. PubMed ID: 31281236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
    de Paula Faria D; de Vries EF; Sijbesma JW; Buchpiguel CA; Dierckx RA; Copray SC
    Mult Scler; 2014 Oct; 20(11):1443-52. PubMed ID: 24622349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis.
    de Paula Faria D; Real CC; Estessi de Souza L; Teles Garcez A; Navarro Marques FL; Buchpiguel CA
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of myelin density using [
    van der Weijden CWJ; Meilof JF; van der Hoorn A; Zhu J; Wu C; Wang Y; Willemsen ATM; Dierckx RAJO; Lammertsma AA; de Vries EFJ
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3492-3507. PubMed ID: 35366079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PET marker for in vivo quantification of myelination.
    Wu C; Wang C; Popescu DC; Zhu W; Somoza EA; Zhu J; Condie AG; Flask CA; Miller RH; Macklin W; Wang Y
    Bioorg Med Chem; 2010 Dec; 18(24):8592-9. PubMed ID: 21071233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal partial volume correction: Application to [
    Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.
    Stankoff B; Freeman L; Aigrot MS; Chardain A; Dollé F; Williams A; Galanaud D; Armand L; Lehericy S; Lubetzki C; Zalc B; Bottlaender M
    Ann Neurol; 2011 Apr; 69(4):673-80. PubMed ID: 21337603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography.
    Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Bongarzone S; Comtat C; Bottlaender M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1771-82. PubMed ID: 26058700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
    Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model.
    de Paula Faria D; Vlaming ML; Copray SC; Tielen F; Anthonijsz HJ; Sijbesma JW; Buchpiguel CA; Dierckx RA; van der Hoorn JW; de Vries EF
    J Nucl Med; 2014 Aug; 55(8):1330-5. PubMed ID: 24914056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.
    Yazdan-Panah A; Bodini B; Soulier T; Veronese M; Bottlaender M; Tonietto M; Stankoff B
    EJNMMI Res; 2024 May; 14(1):50. PubMed ID: 38801594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Tonietto M; Poirion E; Lazzarotto A; Ricigliano V; Papeix C; Bottlaender M; Bodini B; Stankoff B
    Brain; 2023 Jan; 146(1):182-194. PubMed ID: 36097347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo quantification of myelin changes in the vertebrate nervous system.
    Wang Y; Wu C; Caprariello AV; Somoza E; Zhu W; Wang C; Miller RH
    J Neurosci; 2009 Nov; 29(46):14663-9. PubMed ID: 19923299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.